Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19

BACKGROUND: Patients with end-stage kidney disease (ESKD) are highly susceptible to coronavirus disease 2019 (COVID-19) infection and its complications. Remdesivir has improved outcomes in COVID-19 patients but its use has been limited among ESKD patients due to insufficient data regarding safety ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaki, Kirollos E, Huang, Cheng-Wei, Zhou, Hui, Chung, Joanie, Selevan, David C, Rutkowski, Mark P, Sim, John J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452122/
https://www.ncbi.nlm.nih.gov/pubmed/36320364
http://dx.doi.org/10.1093/ckj/sfac185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452122/
https://www.ncbi.nlm.nih.gov/pubmed/36320364
http://dx.doi.org/10.1093/ckj/sfac185

Ejemplares similares